What Is MIRA Pharmaceuticals, Inc. (MIRA) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on MIRA Pharmaceuticals, Inc. at its current price of $0.94. The composite intrinsic value is estimated at $0.57 (-39.7% average return), with 7 models flagging overvaluation risk. The most optimistic model, Sentiment SOTP, places fair value at $1.24 (+32.1%), while ML-RIV — the most conservative — estimates $0.01 (-98.5%). This +130.6% gap reflects genuine analytical uncertainty about MIRA Pharmaceuticals, Inc.'s intrinsic worth.
What Do the Models Say About MIRA?
11 of 13 models are currently active for MIRA. Of these, 2 models suggest upside while 9 models suggest overvaluation. The Bayesian DCF estimates MIRA's intrinsic value at $0.32, implying -66.4% downside from the current price. See which stocks rank higher →
How Does MIRA Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, MIRA ranks #253 by Quality of Company score. CirclFi's QOC score of 4.7/10 evaluates 32 fundamental signals. A score of 4.7 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a pharmaceutical industry, MIRA Pharmaceuticals, Inc. operates in a sector where pipeline depth and stage distribution is a critical driver of valuation. Investors evaluating MIRA should weigh these sector-specific dynamics alongside our model-derived fair values.
Is MIRA a Value Trap?
The Value Trap algorithm is not active for MIRA. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for MIRA Pharmaceuticals, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, MIRA Pharmaceuticals, Inc.'s fundamental quality profile registers 4.7/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +130.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every MIRA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across MIRA's 11 active models, average confidence is 19%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad